REFERENCES
- Press R., Deretzi L.P., Zhu J., Fredman P., Lycke J., Link H. IL-10 and IFN-gamma in Guillain-Barre Syndrome. Network Members of the Swedish Epidemiological Study Group. J. Neuroimmunol. 2001; 112: 129–138
- Hadden R.D., Karch H., Hartung H.P., Zielasek J., Weissbrich B., Schubert J., Weishaupt A., Cornblath D.R., Swan A.V., Hughes R.A., Toyka K.V. Preceding Infections, Immune Factors, and Outcome in Guillain-Barre Syndrome. Neurology 2001; 56: 758–765
- Tagawa Y., Yuki N., Hirata K. Ability to Remove Immunoglobulins and Anti-Ganglioside Antibodies by Plasma Exchange, Double Filtration Plasmapheresis and Immunoadsorption. J. Neurol. Sci. 1998; 157: 90–98
- Nakamura T., Ushiyama C., Hara M., Osada S., Ugal K., Shimada N., Hevashi K., Elbinhara I., Kolde H. Comparative Effects of Plasmaphresis and Intravenous Cyclophosphamide on Urinary Podocyte Excretion in Patients with Proliferative Lupus Nephritis. Clin. Nephrol. 2002; 57: 108–119
- Chen W.H., Yeh J.H., Chiu H.C. Experience of Double Filtration Plasmapheresis in the Treatment of Guillain-Barre Syndrome. J. Clin. Apheresis 1999; 14: 126–129